Literature DB >> 31989285

Deep learning-based automated detection of glaucomatous optic neuropathy on color fundus photographs.

Feng Li1, Lei Yan1, Yuguang Wang1, Jianxun Shi1, Hua Chen1, Xuedian Zhang1, Minshan Jiang2, Zhizheng Wu3, Kaiqian Zhou4.   

Abstract

PURPOSE: To develop a deep learning approach based on deep residual neural network (ResNet101) for the automated detection of glaucomatous optic neuropathy (GON) using color fundus images, understand the process by which the model makes predictions, and explore the effect of the integration of fundus images and the medical history data from patients.
METHODS: A total of 34,279 fundus images and the corresponding medical history data were retrospectively collected from cohorts of 2371 adult patients, and these images were labeled by 8 glaucoma experts, in which 26,585 fundus images (12,618 images with GON-confirmed eyes, 1114 images with GON-suspected eyes, and 12,853 NORMAL eye images) were included. We adopted 10-fold cross-validation strategy to train and optimize our model. This model was tested in an independent testing dataset consisting of 3481 images (1524 images from NORMAL eyes, 1442 images from GON-confirmed eyes, and 515 images from GON-suspected eyes) from 249 patients. Moreover, the performance of the best model was compared with results obtained by two experts. Accuracy, sensitivity, specificity, kappa value, and area under receiver operating characteristic (AUC) were calculated. Further, we performed qualitative evaluation of model predictions and occlusion testing. Finally, we assessed the effect of integrating medical history data in the final classification.
RESULTS: In a multiclass comparison between GON-confirmed eyes, GON-suspected eyes and NORMAL eyes, our model achieved 0.941 (95% confidence interval [CI], 0.936-0.946) accuracy, 0.957 (95% CI, 0.953-0.961) sensitivity, and 0.929 (95% CI, 0.923-0.935) specificity. The AUC distinguishing referrals (GON-confirmed and GON-suspected eyes) from observation was 0.992 (95% CI, 0.991-0.993). Our best model had a kappa value of 0.927, while the two experts' kappa values were 0.928 and 0.925 independently. The best 2 binary classifiers distinguishing GON-confirmed/GON-suspected eyes from NORMAL eyes obtained 0.955, 0.965 accuracy, 0.977, 0.998 sensitivity, and 0.929, 0.954 specificity, while the AUC was 0.992, 0.999 respectively. Additionally, the occlusion testing showed that our model identified the neuroretinal rim region, retinal nerve fiber layer (RNFL) defect areas (superior or inferior) as the most important parts for the discrimination of GON, which evaluated fundus images in a way similar to clinicians. Finally, the results of integration of fundus images with medical history data showed a slight improvement in sensitivity and specificity with similar AUCs.
CONCLUSIONS: This approach could discriminate GON with high accuracy, sensitivity, specificity, and AUC using color fundus photographs. It may provide a second opinion on the diagnosis of glaucoma to the specialist quickly, efficiently and at low cost, and assist doctors and the public in large-scale screening for glaucoma.

Entities:  

Keywords:  Automated detection; Color fundus photographs; Deep residual neural network; Glaucomatous optic neuropathy; Integration of medical data

Mesh:

Year:  2020        PMID: 31989285     DOI: 10.1007/s00417-020-04609-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  23 in total

1.  Transient changes of intraocular pressure and anterior segment configuration after diagnostic mydriasis with 1% tropicamide in children.

Authors:  I-Lun Tsai; Ching-Yao Tsai; Li-Lin Kuo; Shiow-Wen Liou; Shan Lin; I-Jong Wang
Journal:  Clin Exp Optom       Date:  2011-11-14       Impact factor: 2.742

2.  Visualizing Deep Learning Models for the Detection of Referable Diabetic Retinopathy and Glaucoma.

Authors:  Stuart Keel; Jinrong Wu; Pei Ying Lee; Jane Scheetz; Mingguang He
Journal:  JAMA Ophthalmol       Date:  2019-03-01       Impact factor: 7.389

3.  From Machine to Machine: An OCT-Trained Deep Learning Algorithm for Objective Quantification of Glaucomatous Damage in Fundus Photographs.

Authors:  Felipe A Medeiros; Alessandro A Jammal; Atalie C Thompson
Journal:  Ophthalmology       Date:  2018-12-20       Impact factor: 12.079

4.  Glaucoma Screening in Nepal: Cup-to-Disc Estimate With Standard Mydriatic Fundus Camera Compared to Portable Nonmydriatic Camera.

Authors:  Sarah E Miller; Suman Thapa; Alan L Robin; Leslie M Niziol; Pradeep Y Ramulu; Maria A Woodward; Indira Paudyal; Ian Pitha; Tyson N Kim; Paula Anne Newman-Casey
Journal:  Am J Ophthalmol       Date:  2017-07-19       Impact factor: 5.258

5.  Quality and content analysis of fundus images using deep learning.

Authors:  Renoh Johnson Chalakkal; Waleed Habib Abdulla; Sinumol Sukumaran Thulaseedharan
Journal:  Comput Biol Med       Date:  2019-03-26       Impact factor: 4.589

6.  Efficacy of a Deep Learning System for Detecting Glaucomatous Optic Neuropathy Based on Color Fundus Photographs.

Authors:  Zhixi Li; Yifan He; Stuart Keel; Wei Meng; Robert T Chang; Mingguang He
Journal:  Ophthalmology       Date:  2018-03-02       Impact factor: 12.079

7.  Automated Diagnosis of Glaucoma Using Empirical Wavelet Transform and Correntropy Features Extracted From Fundus Images.

Authors:  Shishir Maheshwari; Ram Bilas Pachori; U Rajendra Acharya
Journal:  IEEE J Biomed Health Inform       Date:  2016-03-22       Impact factor: 5.772

8.  Optic disc, cup and neuroretinal rim size, configuration and correlations in normal eyes.

Authors:  J B Jonas; G C Gusek; G O Naumann
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-07       Impact factor: 4.799

Review 9.  The pathophysiology and treatment of glaucoma: a review.

Authors:  Robert N Weinreb; Tin Aung; Felipe A Medeiros
Journal:  JAMA       Date:  2014-05-14       Impact factor: 56.272

10.  Development of a deep residual learning algorithm to screen for glaucoma from fundus photography.

Authors:  Naoto Shibata; Masaki Tanito; Keita Mitsuhashi; Yuri Fujino; Masato Matsuura; Hiroshi Murata; Ryo Asaoka
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

View more
  7 in total

1.  Comparison between Deep-Learning-Based Ultra-Wide-Field Fundus Imaging and True-Colour Confocal Scanning for Diagnosing Glaucoma.

Authors:  Younji Shin; Hyunsoo Cho; Yong Un Shin; Mincheol Seong; Jun Won Choi; Won June Lee
Journal:  J Clin Med       Date:  2022-06-02       Impact factor: 4.964

2.  Deep learning on fundus images detects glaucoma beyond the optic disc.

Authors:  Ruben Hemelings; Bart Elen; João Barbosa-Breda; Matthew B Blaschko; Patrick De Boever; Ingeborg Stalmans
Journal:  Sci Rep       Date:  2021-10-13       Impact factor: 4.379

3.  A cascade eye diseases screening system with interpretability and expandability in ultra-wide field fundus images: A multicentre diagnostic accuracy study.

Authors:  Jing Cao; Kun You; Jingxin Zhou; Mingyu Xu; Peifang Xu; Lei Wen; Shengzhan Wang; Kai Jin; Lixia Lou; Yao Wang; Juan Ye
Journal:  EClinicalMedicine       Date:  2022-09-05

4.  Deep learning-based automated detection for diabetic retinopathy and diabetic macular oedema in retinal fundus photographs.

Authors:  Feng Li; Yuguang Wang; Tianyi Xu; Lin Dong; Lei Yan; Minshan Jiang; Xuedian Zhang; Hong Jiang; Zhizheng Wu; Haidong Zou
Journal:  Eye (Lond)       Date:  2021-07-01       Impact factor: 4.456

Review 5.  A Review of Deep Learning for Screening, Diagnosis, and Detection of Glaucoma Progression.

Authors:  Atalie C Thompson; Alessandro A Jammal; Felipe A Medeiros
Journal:  Transl Vis Sci Technol       Date:  2020-07-22       Impact factor: 3.283

Review 6.  Review of Machine Learning Applications Using Retinal Fundus Images.

Authors:  Yeonwoo Jeong; Yu-Jin Hong; Jae-Ho Han
Journal:  Diagnostics (Basel)       Date:  2022-01-06

7.  [Glaucoma care in Germany-Results of a survey among German ophthalmologists-Part 1: diagnostics].

Authors:  Christian Wolfram; Alexander K Schuster
Journal:  Ophthalmologe       Date:  2021-03-17       Impact factor: 1.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.